Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study - Gouw,S.C.; van der Bom,J.G.; Auerswald,G.; Ettinghausen,C.E.; Tedgård,U.; van den Berg,H.M. (Blood, 2007)